IP Verse

Oil/Water-Emulsion-Type Topical Compositions Containing A Retinoid - EP2854802

The patent EP2854802 was granted to Galderma Research on Aug 24, 2022. The application was originally filed on May 30, 2013 under application number EP13726504A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2854802

GALDERMA RESEARCH
Application Number
EP13726504A
Filing Date
May 30, 2013
Status
Patent Maintained As Amended
Jul 22, 2022
Grant Date
Aug 24, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKApr 24, 2019HGFADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0826366
DESCRIPTIONEP0989846
DESCRIPTIONEP1831149
DESCRIPTIONUS5851538
INTERNATIONAL-SEARCH-REPORTFR2915682
INTERNATIONAL-SEARCH-REPORTWO2006066978
OPPOSITIONEP1831149
OPPOSITIONEP2065032
OPPOSITIONUS2006110415
OPPOSITIONUS2011070274
OPPOSITIONUS6531141
OPPOSITIONUS7820186
OPPOSITIONWO2008148968
OPPOSITIONWO2008152064

Non-Patent Literature (NPL) Citations (8) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- DE THIELITZ, AM J CLIN DERMATOL., (2008), vol. 9, no. 6, pages 369 - 81
DESCRIPTION- STÜCKER, SKIN RES TECHNOL., (200205), vol. 8, no. 2, pages 133 - 40
OPPOSITION- "Clnical Trial Results Eudract number 2010-024214-54", EU Clinical Trials Register, (20160615), URL: https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024214-54/results, XP055587245
OPPOSITION- "Double-Blind Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris", ClinicalTrials.gov, (20150922), URL: https://clinicaltrials.gov/ct2/show/NCT02556788, XP055580449
OPPOSITION- "EudraCT Number 2008-007981-44", EU Clinical Trials Register, (20090317), URL: https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007981-44/ FR, XP055587237
OPPOSITION- "EudraCT number 2010-022211-19/DE", EU Clinical Trials Register, (20100923), URL: https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022211-19/ DE, XP055587304
OPPOSITION- "EudraCT number 2010-024214-54", EU Clinical Trials Register,, (20160515), URL: https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024214-54/ BE, XP055587233
OPPOSITION- "LauroglycolTM 90", Gattefossé, (20190000), URL: https://www.gattefosse.com/lauroglycol-90, XP055587230

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents